Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan · Delayed Price · Currency is TWD 105.00
-1.00 (-0.94%)
At close: Jul 29, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 5.5 billion as of July 29, 2026. Its market cap has increased by 57.59% in one year.
Market Cap
5.50B
Enterprise Value
5.16B
Revenue
5.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
105.00
ChartMarket Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 5.50B, an increase of 163.11%. That is a compound annual growth rate of 8.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 5.50B | -4.03% |
| Dec 31, 2025 | 5.73B | 151.98% |
| Dec 31, 2024 | 2.27B | 1,107.48% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 10.06B |
| TEH SENG Pharmaceutical Mfg. | 2.58B |
| Libo Pharma | 2.24B |
| Anbogen Therapeutics | 1.87B |
| Timing Pharmaceutial | 1.69B |
| TSA International | 1.58B |
| Protect Animal Health | 1.51B |
| Anya Biopharm | 1.48B |